Selected Publication:
SHR
Neuro
Cancer
Cardio
Lipid
Metab
Microb
Bornemann-Cimenti, H; Sivro, N; Toft, F; Halb, L; Sandner-Kiesling, A.
[Neuraxial anesthesia in patients with multiple sclerosis - a systematic review].
Rev Bras Anestesiol. 2017; 67(4):404-410
Doi: 10.1016/j.bjan.2016.09.015
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
- Leading authors Med Uni Graz
-
Bornemann-Cimenti Helmar
- Co-authors Med Uni Graz
-
Sampl Larissa
-
Sandner-Kiesling Andreas
-
Sivro Nikki Sabrina
- Altmetrics:
- Dimensions Citations:
- Plum Analytics:
- Scite (citation analytics):
- Abstract:
-
Current guidelines for neuraxial analgesia in patients with multiple sclerosis are ambiguous and offer the clinician only a limited basis for decision making. This systematic review examines the number of cases in which multiple sclerosis has been exacerbated after central neuraxial analgesia in order to rationally evaluate the safety of these procedures.
A systematic literature search with the keywords "anesthesia or analgesia" and "epidural, peridural, caudal, spinal, subarachnoid or intrathecal" in combination with "multiple sclerosis" was performed in the databases PubMed and Embase, looking for clinical data on the effect of central neuraxial analgesia on the course of multiple sclerosis.
Over a period of 65 years, our search resulted in 37 reports with a total of 231 patients. In 10 patients multiple sclerosis was worsened and nine multiple sclerosis or neuromyelitis optica was first diagnosed in a timely context with central neuraxial analgesia. None of the cases showed a clear relation between cause and effect. Current clinical evidence does not support the theory that central neuraxial analgesia negatively affects the course of multiple sclerosis.
Copyright © 2016 Sociedade Brasileira de Anestesiologia. Publicado por Elsevier Editora Ltda. All rights reserved.
- Find related publications in this database (Keywords)
-
Multiple sclerosis
-
Neuromyelitis optica
-
Neuroaxial anesthesia